Matinas BioPharma | Investor Presentation Deck

Slide schematic 8/8

callout 1/1 list 6/6 title 1/1

Components 8

primary bullet bullet bullet bullet bullet bullet headline

Tools 1

list/bullet: 20 patients with no other treatment options have enrolled to receive or have completed treatment with MAT2203. Notable Healthcare Institutions: NIH, University of Michigan, Johns Hopkins, City of Hope, Natio

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 0

∅

No frameworks

No framework match is anchored to this slide.

Find anything

Highlights clinical success in patients who failed or could not tolerate standard azole or IV Amphotericin B therapies.